Akouos is a precision genetic medicine company focused on developing gene therapies to treat hearing disorders. It advances candidate therapies that target sensory cells, such as inner hair cells, and nonsensory cells, such as supporting cells. The company offers AK-OTOF, an adeno-associated viruses gene therapy intended for the treatment of, and potential restoration of hearing in, individuals with sensorineural hearing loss due to mutations in the otoferlin gene.